Waters (NYSE:WAT) Receiving Somewhat Favorable Media Coverage, Report Shows
Media coverage about Waters (NYSE:WAT) has trended somewhat positive this week, Accern Sentiment reports. The research firm scores the sentiment of news coverage by monitoring more than twenty million news and blog sources. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Waters earned a media sentiment score of 0.21 on Accern’s scale. Accern also assigned media stories about the medical instruments supplier an impact score of 45.568006347032 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the near future.
These are some of the news articles that may have impacted Accern’s scoring:
- HyperGrid Continues Momentum with Bookings and Customer Acquisitions Doubling in 2017 Compared to 2016 (prweb.com)
- Waters New ACQUITY Arc Bio System Brings Advanced Method Transfer Capabilities to Routine Bioseparations (markets.financialcontent.com)
- Guangzhou Olansi Healthcare Co., Ltd Is Leading Name for Hydrogen Water Generators & Air & Water Purifiers (menafn.com)
- Kids losing ability to swim as more schools close their pools, says Water Safety boss (stuff.co.nz)
- Cape Town stock piling drinking water (herald.co.zw)
Several equities research analysts have recently commented on the stock. William Blair reaffirmed an “outperform” rating on shares of Waters in a research report on Tuesday, January 23rd. BTIG Research reissued a “buy” rating on shares of Waters in a research report on Thursday, January 25th. Citigroup lifted their target price on shares of Waters from $190.00 to $223.00 and gave the stock a “neutral” rating in a report on Wednesday, January 24th. JPMorgan Chase & Co. lifted their target price on shares of Waters from $180.00 to $200.00 and gave the stock a “neutral” rating in a report on Wednesday, January 24th. Finally, Barclays lifted their target price on shares of Waters from $202.00 to $208.00 and gave the stock an “equal weight” rating in a report on Wednesday, January 24th. Twelve analysts have rated the stock with a hold rating, six have assigned a buy rating and one has assigned a strong buy rating to the stock. Waters has an average rating of “Hold” and an average target price of $203.75.
Waters (NYSE:WAT) last released its earnings results on Tuesday, January 23rd. The medical instruments supplier reported $2.51 EPS for the quarter, topping the consensus estimate of $2.44 by $0.07. Waters had a net margin of 0.88% and a return on equity of 24.70%. The firm had revenue of $687.28 million for the quarter, compared to the consensus estimate of $671.98 million. During the same quarter in the previous year, the firm earned $2.21 earnings per share. The company’s quarterly revenue was up 9.3% compared to the same quarter last year. research analysts expect that Waters will post 8.16 EPS for the current year.
In other Waters news, SVP Elizabeth B. Rae sold 12,000 shares of the business’s stock in a transaction on Friday, November 3rd. The shares were sold at an average price of $197.95, for a total transaction of $2,375,400.00. Following the transaction, the senior vice president now owns 18,129 shares in the company, valued at $3,588,635.55. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, SVP Mark T. Beaudouin sold 42,143 shares of the business’s stock in a transaction on Thursday, January 25th. The shares were sold at an average price of $217.21, for a total transaction of $9,153,881.03. Following the transaction, the senior vice president now owns 20,749 shares in the company, valued at approximately $4,506,890.29. The disclosure for this sale can be found here. Insiders sold 108,389 shares of company stock worth $22,239,163 in the last three months. Insiders own 5.07% of the company’s stock.
Waters Company Profile
Waters Corporation is an analytical instrument manufacturer. The Company operates through two segments: Waters and TA. It designs, manufactures, sells and services high performance liquid chromatography (HPLC), ultra performance liquid chromatography (UPLC and together with HPLC, referred to as LC) and mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products and post-warranty service plans.
Receive News & Ratings for Waters Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters and related companies with MarketBeat.com's FREE daily email newsletter.